The metabolic syndrome. Part I: Definitions and diagnostic criteria for its identification. Epidemiology and relationship with cardiovascular and type 2 diabetes risk;Zespół metaboliczny. Częs̈ć I: Definicje i kryteria rozpoznawania zespołu metabolicznego. Epidemiologia oraz związek z ryzykiem chorób sercowo-naczyniowych i cukrzycy typu 2

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 62, Issue , 2008, Pages 530-542

  Pacholczyk, Marta ^a   Ferenc, Tomasz ^a   Kowalski, Jan ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Definitions; Diagnostic criteria for its identification; Epidemiology; Metabolic syndrome; Relationship with cardiovascular and type 2 diabetes risk

Indexed keywords

ADULT; CARDIOVASCULAR DISEASE; COMORBIDITY; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; RISK FACTOR;

ADULT; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; RISK FACTORS;

EID: 60649085467     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Alberti K.G., Zimmet P.Z.: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classifi-cation of diabetes mellitus: provisional report of WHO consultation. Diabetes Med., 1998; 15: 539-553
2. Alberti G., Zimmet P.Z., Shaw J., Grundy S.M., International Diabetes Federation 2006: The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/IDF-Meta-def-final.pdf (05-09.2008)
3. Alexander C.M.: The coming of age of the metabolic syndrome. Diabetes Care, 2003; 26: 3180-3181
4. Alexander C.M., Landsman P.B., Teutsch S.M., Haffner S.M.: NCEPdefined metabolic syndrome, diabetes, and prevalene of coronary heart disease among NHANES III participants age 50 year and older. Diabetes, 2003; 52: 1210-1214
5. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care, 2004; 27(Suppl.1): S5-S10
6. Balkau B., Charles M.A.: Comment of the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet. Med., 1999; 16: 442-443
7. Balkau B., Charles M.A., Drivsholm T., Borch-Johnsen K., Wareham N., Yudkin J.S., Morris R., Zavaroni I., van Dam R., Feskins E., Gabriel R., Diet M., Nilsson P., Hedblad B.: The European Group for the Study of Insulin Resistance (EGIR): Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab., 2002; 28: 364-376
8. Balkau B., Vernay M., Mhamdi L., Novak M., Arondel D., Vol S., Tichet J., Eschwege E., The D.E.S.I.R. Study Group: The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab., 2003; 29: 526-532
9. Braunwald E.: Shattuck lecture . cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N. Engl. J. Med., 1997; 337: 1360-1369
10. Broda G., Szcze.niewska D., Rywik S.: Cz.sto.. wyst.powania zespo.u metabolicznego w populacji osob doros.ych Warszawy. Med. Metab., 2003; 7: 225-229
11. Bruno G., Merletti F., Biggeri A., Bargero G., Ferrero S., Runzo C., Prina Cerai S., Pagano G., Cavallo-Perin P.: Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes. Diabetes Care, 2004; 27: 2689-2694
12. Cowey S., Hardy R.W.: The metabolic syndrome. A high-risk state for cancer? Am. J. Pathol., 2006; 169: 1505-1522
13. Eckel R.H., Grundy S.M., Zimmet P.Z.: The metabolic syndrome. Lancet, 2005; 365: 1415-1428
14. Einhorn D., Reaven G.M., Cobin R.H., Ford E., Ganda O.P., Handelsman Y., Hellman R., Jellinger P.S., Kendall D., Krauss R.M., Neufeld N.D., Petak S.M., Rodbard H.W., Seibel J.A., Smith D.A., Wilson P.W.: American College of Endocrinology position statement on the insulin resistance syndrome. Endocr. Pract., 2003; 9: 237-252
15. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001; 285: 2486-2497
16. Ford E.S.: Risk for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. A summary of the evidence. Diabetes Care, 2005; 28: 1769-1778
17. Ford E.S., Giles W.H.: A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care, 2003; 26: 575-581
18. Ford E.S., Giles W.H., Dietz W.H.: Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359
19. Ford E.S., Giles W.H., Mokdad A.H.: Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care, 2004; 27: 2444-2449
20. Grundy S.M.: Does a diagnosis of metabolic syndrome have value in clinical practise? Am. J. Clin. Nutr. 2006; 83: 1248-1251
21. Grundy S.M., Brewer H.B.Jr, Cleeman J.I., Smith S.C.Jr, Lenfant C.: Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438
22. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Spertus J.A., Costa F.: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 2005; 112: 2735-2752
23. Grundy S.M., Hansen B., Smith S.C., Cleeman J.I., Kahn R.A.: Clinical management of metabolic syndrome. Report of the American Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation, 2004; 109: 551-556
24. Hanley A.J., Karter A.J., Williams K., Festa A., D'Agostino R.B.Jr, Wagenknecht L.E., Haffner S.M.: Prediction of type 2 diabetes mellitus with alternative deffinition of the metabolic syndrome. The Insulin Resistance Atherosclerosis Study. Circulation, 2005; 112: 3713-3721
25. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., Taskinen M.R., Groop L.: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001; 24: 683-689
26. Jeppesen J., Hein H.O., Suadicani P., Gyntelberg F.: Low triglicerydes, high high-density lipoprotein cholesterol and risk of ischaemic heart disease: Arch. Intern. Med., 2001; 161: 361-366
27. Kahn R., Buse J., Ferrannini E., Stern M.: The metabolic syndrome: time for a critical appraisal. Diabetes Care, 2005; 28: 2289-2304
28. Kaplan N.M.: The deadly quartet: upper-body obesity, glucose intolerance, hypertriglicerydemia and hypertension. Arch. Intern. Med., 1989; 149: 1514-1520
29. Klein B.E.K., Klein R., Lee K.E.: Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care, 2002; 25: 1790-1794
30. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., Salonen J.T.: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA, 2002; 288: 2709-2716
31. Lemieux I., Pascot A., Couillard C., Lamarche B., Tchernof A., Almeras N., Bergeron J., Gaudet D., Tremblay G., Prud'homme D., Nadeau A., Despres J.P.: Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small dense LDL) in men? Circulation, 2000; 102: 179-184
32. Lewis G.F., Carpentier A., Adeli K., Giacca A.: Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev., 2002; 23: 201-229
33. Liao Y., Kwon S., Shaughnessy S., Wallace P., Hutto A., Jenkins A.J., Klein R.L., Garvey W.T.: Critical evaluation of Adult Treatment Panel III criteria in identyfying insulin resistance with dyslipidemia. Diabetes Care, 2004; 27: 978-983
34. Liese A.D., Mayer-Davis E.J., Haffner S.M.: Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol. Rev., 1998; 20: 157-172
35. Malik S., Wong N.D., Franklin S.S., Kamath T.V., L'Italien G.J., Pio J.R., Williams G.R.: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease and all causes in United States adults. Circulation, 2004; 110: 1245-1250
36. Meigs J.B., Wilson P.W., Nathan D.M., D'Agostino R.B.Sr, Williams K., Haffner S.M.: Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes, 2003; 52: 2160-2167
37. National Cholesterol Education Program National Heart, Lung, and Blood Institutes of Health NIH Publication No. 02-5215 September 2002: Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation, 2002; 106: 3143-3421
38. Ninomiya J.K., L'Italien G., Criqui M.H., Whyte J.L., Gamst A., Chen R.S.: Association of the metabolic syndrome with history of myocardial infraction and stroke in the Third National Health and Nutrition Examination Survey. Circulation, 2004; 109: 42-46
39. Qiao Q., Pyorala K., Tuomilehto J., Gao W.G., Hu G., Peltonen M., Dekker J.M., Alberti K.G.M.M. . The Decode Study Group: Comparison of three different definitions for the metabolic syndrome in non-diabetic Europeans. Br. J. Diabetes Vasc. Dis., 2005; 5: 161-168
40. Reaven G.M.: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 1988; 37: 1595-1607
41. Reaven G.M.: The metabolic syndrome: is this diagnosis necessary? Am. J. Clin. Nutr., 2006; 83: 1237-1247
42. Reaven G.: The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol. Metab. Clin. North. Am., 2004; 33: 283-303
43. Reaven G.M.: The metabolic syndrome: requiescat in pace. Clin. Chem., 2005; 51: 931-938
44. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., Isles C., Macfarlane P.W., Packard C.J., Cobbe S.M., Shepherd J.: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 2003; 108: 414-419
45. Schmidt M.I., Duncan B.B., Watson R.L., Sharrett A.R., Brancati F.L., Heiss G.: A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care, 1996; 19: 414-418
46. Sheu W.H., Jeng C.Y., Shieh S.M., Fuh M.M., Shen D.D., Chen Y.D., Reaven G.M.: Insulin resistance and abnormal electrocardiograms in patients with high blood pressure. Am. J. Hypertens., 1992; 5: 444-448
47. Stern M.P., Williams K., Gonzales-Villalpando C., Hunt K.J., Haffner S.M.: Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care, 2004; 27: 2676-2681
48. Tuan C., Abbasi F., Lamendola C., McLaughlin T., Reaven G.: Usefulness of plasma glucose and insulin concentrations in identifying patients with insulin resistance. Am. J. Cardiol., 2003; 92: 606-610
49. Wang J., Thornton J.C., Bari S., Williamson B., Gallagher D., Heymsfield S.B., Horlick M., Kotler D., Laferrère B., Mayer L., Pi-Sunyer F.X., Pierson R.N. Jr.: Comparison of waist circumferences measured at 4 sites. Am. J. Clin. Nutr., 2003; 77: 379-384
50. Weiss R., Dziura J., Burgert T.S., Tamborlane W.V., Taksali S.E., Yeckel C.W., Allen K., Lopes M., Savoye M., Morrison J., Sherwin R.S., Caprio S.: Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med., 2004; 350: 2362-2374
51. Wyrzykowski B., Zdrojewski T., Sygnowska E., Biela U., Drygas W., Tykarski A., Kozakiewicz K., Broda G.: Epidemiologia zespołu metabolicznego w Polsce. Wyniki programu WOBASZ. Kardiol. Pol., 2005; 63(Supl.4): S1-S4
52. Zdrojewski T., Bandosz P., Szpakowski P., Konarski R., Manikowski A., Wołkiewicz E., Jakubowski Z., Łysiak-Szydłowska W., Bautembach S., Wyrzykowski B.: Rozpowszechnienie głównych czynników ryzyka chorób układu sercowo-naczyniowego w Polsce. Wyniki badania NATPOL PLUS. Kardiol. Pol., 2004, 61(Supl.IV): IV1-IV26